BioScience Health Innovations, Inc.
BHIC
$4.49
$0.4912.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.04M | 750.90K | 1.57M | 1.13M | 1.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.04M | 750.90K | 1.57M | 1.13M | 1.76M |
| Cost of Revenue | 376.90K | 265.40K | 1.00M | 433.20K | 683.00K |
| Gross Profit | 659.50K | 485.60K | 571.90K | 698.20K | 1.07M |
| SG&A Expenses | 877.40K | 715.50K | 728.50K | 707.00K | 616.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.25M | 980.90K | 1.73M | 1.14M | 1.30M |
| Operating Income | -217.90K | -229.90K | -156.70K | -8.80K | 457.70K |
| Income Before Tax | -217.90K | -229.90K | -156.70K | -8.80K | 457.70K |
| Income Tax Expenses | -32.10K | -- | 77.00K | -- | -- |
| Earnings from Continuing Operations | -185.80K | -229.90K | -233.60K | -8.80K | 457.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -185.80K | -229.90K | -233.60K | -8.80K | 457.70K |
| EBIT | -217.90K | -229.90K | -156.70K | -8.80K | 457.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.02 | -0.02 | 0.00 | 0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.03 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | 0.00 | 0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.03 |
| Average Basic Shares Outstanding | 11.68M | 11.38M | 10.98M | 10.98M | 10.98M |
| Average Diluted Shares Outstanding | 11.68M | 11.38M | 10.98M | 10.98M | 11.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |